Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This pilot randomized controlled trial evaluated the feasibility of using SMS messaging to enhance medication adherence in individuals with Type 2 diabetes.
This pilot study evaluated a mobile insulin titration intervention for transitioning patients with Type 2 Diabetes from basal insulin to GLP-1 receptor agonists, showing promising outcomes.
The study evaluated the impact of the SNAQ meal analysis app on glucose control in adults with type 1 diabetes using automated insulin delivery (AID) systems.
This study investigated the effects of sodium butyrate supplementation on gastrointestinal symptoms in patients with type 2 diabetes and IBS, finding significant improvements in various symptoms.
This study evaluated the impact of a structured food sequencing approach combined with mHealth dietary monitoring on maternal glycemic control in women with gestational diabetes mellitus, showing significant improvements in several health outcomes.
This study investigated the anti-diabetic effects of sumac in patients with type 2 diabetes, finding significant improvements in fasting blood sugar and HbA1C levels.
This Phase II study evaluated the effects of Survodutide on HbA1c levels and bodyweight in adults with Type 2 Diabetes, finding significant reductions in both outcomes compared to baseline.
This study evaluated the efficacy of Suvorexant in improving sleep and health outcomes in individuals with Type 2 diabetes and insomnia, finding no significant improvements.
Switching from DPP-4 inhibitors to oral semaglutide improved oxidative stress and glycemic parameters in patients with type 2 diabetes.
This small trial analysis tested daily tadalafil in people with type 2 diabetes. Tadalafil lowered some blood biomarkers related to amyloid metabolism and astroglial activation, but it did not change several other brain-related biomarkers.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
